Evidence map›Paper›PMID 42286698›Full record

ArticleAntimicrobial resistance and infection control2026

Audit of the prescription of antimicrobials using the four moments of decision tool in a university hospital.

Amanda Magalhães Vilas Boas Cambiais, Vanusa Barbosa Pinto, Andréa Cassia Pereira Sforsin, Luiz Marcelo Sa Malbouisson, Arnaldo Lichtenstein, Nelson De Luccia, Aleia Faustina Campos, Ícaro Boszczowski, Silvia Figueiredo Costa, Thaís Guimarães

Abstract read
In one paragraph

Article in Antimicrobial resistance and infection control, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amanda Magalhães Vilas Boas CambiaisDivision of Pharmacy, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Vanusa Barbosa PintoDivision of Pharmacy, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Andréa Cassia Pereira SforsinDivision of Pharmacy, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Luiz Marcelo Sa MalbouissonIntensive Care Unit, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Arnaldo LichtensteinClinical Medicine Department, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Nelson De LucciaVascular Surgery Department, Instituto Central, Hospital das Clínicas, São Paulo, Brazil.
Aleia Faustina CamposInfection Control Department, Instituto Central, Hospital das Clínicas, São Paulo, SP, 04517-050, Brazil.
Ícaro BoszczowskiInfection Control Department, Instituto Central, Hospital das Clínicas, São Paulo, SP, 04517-050, Brazil.
Silvia Figueiredo CostaInfection Control Department, Instituto Central, Hospital das Clínicas, São Paulo, SP, 04517-050, Brazil.
Thaís GuimarãesInfection Control Department, Instituto Central, Hospital das Clínicas, São Paulo, SP, 04517-050, Brazil. thais.guimaraes@hc.fm.usp.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAntimicrobial resistance is a growing global threat driven by inappropriate antimicrobial use. The Four Moments of Antibiotic Decision Making is a stewardship framework that promotes rational antibiotic use. This study applied this framework to audit antimicrobial prescribing, assess adherence, and measure antimicrobial use.

methodsWe conducted a retrospective, cross-sectional audit of patients who received systemic antimicrobials between October and November 2023. The four audited moments included: (1) indication, suspected site, and clinical evidence of infection; (2) antimicrobial selection and culture collection; (3) reassessment between days 3 and 5 based on clinical response and culture results; and (4) treatment duration. Antimicrobial consumption was measured using days of therapy (DOT), length of therapy (LOT) and the WHO AWaRe classification.

resultsA total of 228 patients (53.5% male; mean age 57 years) received 304 antimicrobial treatments, including 129 intensive care units (ICU) admissions. 75.0% were fully adherent to all Four Moments. Adherence rates across moments 1 to 4 were 97%, 88.8%, 89.3%, and 87.1%, respectively. In moment 2, cultures were indicated in 201 treatments but not requested in 15% of cases. Vancomycin was the most prolonged treatment, followed by ceftriaxone, piperacillin-tazobactam, and meropenem. Antimicrobial use was higher in ICUs, with DOT and LOT reaching 739 and 706 per 1,000 patient-days, respectively, compared with 496 and 319 in the wards. Most antimicrobial consumption corresponded to WHO AWaRe Watch antibiotics.

conclusionsAdherence to stewardship principles was high, although opportunities for improvement remain, particularly regarding culture collection and treatment duration optimization.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsAntimicrobial StewardshipDrug PrescriptionsAgedCross-Sectional StudiesFemaleGuideline AdherenceHospitals, UniversityHumansIntensive Care UnitsMaleMiddle AgedRetrospective StudiesAnti-Bacterial AgentsAnti-Infective AgentsAntibiotic prescribingAntimicrobial resistanceAntimicrobial stewardshipHospital auditInfection control

Identifiers

PMID42286698
PMCPMC13488170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.